GlaxoSmithKline Pharmaceuticals today reported 3.45 per cent rise in standalone net profit at Rs 98.85 crore for the second quarter ended September 30, 2017.
It had posted a net profit of Rs 95.55 crore for the July-September period of the previous fiscal, GSK Pharma said in a BSE filing.
Standalone total income from the operations also rose to Rs 799.12 crore for the quarter under review against Rs 717.53 crore in the same period a year ago.
GSK Pharma stock ended down by 0.65 per cent at Rs 2,901.35.